Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation - Data from RACE 3

被引：9

作者：

Bao-Oanh Nguyen ^{[1
]}

Rienstra, Michiel ^{[1
]}

Hobbelt, Anne H. ^{[1
]}

Tijssen, Jan G. P. ^{[2
]}

Smit, Marcelle D. ^{[3
]}

Tieleman, Robert G. ^{[3
]}

Geelhoed, Bastiaan ^{[1
]}

Van Veldhuisen, Dirk J. ^{[1
]}

Crijns, Harry J. G. M. ^{[4
,5
]}

Van Gelder, Isabelle C. ^{[1
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands

[2] Acad Med Ctr Amsterdam, Clin Epidemiol & Biostat, Amsterdam, Netherlands

[3] Martini Hosp, Groningen, Netherlands

[4] Maastricht Univ, Med Ctr, Maastricht, Netherlands

[5] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands

来源：

AMERICAN HEART JOURNAL | 2020年 / 226卷

关键词：

CATHETER ABLATION; TRIAL;

D O I：

10.1016/j.ahj.2019.12.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is a progressive disease, and maintenance of sinus rhythm is cumbersome. In this analysis of the Routine versus Aggressive risk factor driven upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) trial we aimed to determine whether optimal treatment of underlying conditions of AF improves maintenance of sinus rhythm in patients with persistent AF and moderate heart failure (HF). Our data showed that optimal treatment of blood pressure, LDL-cholesterol and heart failure was associated with an increase in sinus rhythm maintenance compared to conventional therapy (87% versus 63%, P = .002, respectively).

引用

页码：235 / 239

页数：5

共 12 条

[1] Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults [J].

Emdin, Connor A. ;

Anderson, Simon G. ;

Salimi-Khorshidi, Gholamreza ;

Woodward, Mark ;

MacMahon, Stephen ;

Dwyer, Terrence ;

Rahimi, Kazem .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2017, 46 (01) :162-172

[2] Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis [J].

Healey, JS ;

Baranchuk, A ;

Crystal, E ;

Morillo, CA ;

Garfinkle, M ;

Yusuf, S ;

Connolly, SJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) :1832-1839

[3]

Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.5603/KP.2016.0172, 10.1093/europace/euw295]

[4] Catheter Ablation for Atrial Fibrillation with Heart Failure [J].

Marrouche, Nassir F. ;

Brachmann, Johannes ;

Andresen, Dietrich ;

Siebels, Juergen ;

Boersma, Lucas ;

Jordaens, Luc ;

Merkely, Bela ;

Pokushalov, Evgeny ;

Sanders, Prashanthan ;

Proff, Jochen ;

Schunkert, Heribert ;

Christ, Hildegard ;

Vogt, Juergen ;

Baensch, Dietmar .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (05) :417-427

[5] Atrial Remodeling and Atrial Fibrillation [J].

Nattel, Stanley ;

Harada, Masahide .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) :2335-2345

[6] Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]) [J].

Parkash, Ratika ;

Wells, George A. ;

Sapp, John L. ;

Healey, Jeffrey S. ;

Tardif, Jean-Claude ;

Greiss, Isabelle ;

Rivard, Lena ;

Roux, Jean-Francois ;

Gula, Lorne ;

Nault, Isabelle ;

Novak, Paul ;

Birnie, David ;

Ha, Andrew ;

Wilton, Stephen B. ;

Mangat, Iqwal ;

Gray, Christopher ;

Gardner, Martin ;

Tang, Anthony S. L. .

CIRCULATION, 2017, 135 (19) :1788-+

[7] Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation [J].

Pathak, Rajeev K. ;

Middeldorp, Melissa E. ;

Lau, Dennis H. ;

Mehta, Abhinav B. ;

Mahajan, Rajiv ;

Twomey, Darragh ;

Alasady, Muayad ;

Hanley, Lorraine ;

Antic, Nicholas A. ;

McEvoy, R. Doug ;

Kalman, Jonathan M. ;

Abhayaratna, Walter P. ;

Sanders, Prashanthan .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (21) :2222-2231

[8] Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial [J].

Rienstra, Michiel ;

Hobbelt, Anne H. ;

Alings, Marco ;

Tijssen, Jan G. P. ;

Smit, Marcelle D. ;

Brugemann, Johan ;

Geelhoed, Bastiaan ;

Tieleman, Robert G. ;

Hillege, Hans L. ;

Tukkie, Raymond ;

Van Veldhuisen, Dirk J. ;

Crijns, Harry J. G. M. ;

Van Gelder, Isabelle C. .

EUROPEAN HEART JOURNAL, 2018, 39 (32) :2987-2996

[9] New treatment options for atrial fibrillation: towards patient tailored therapy [J].

Smit, Marcelle D. ;

Van Gelder, Isabelle C. .

HEART, 2011, 97 (21) :1796-1802

[10]

Wijtvliet P, 2019, EUR HEART J

← 1 2 →